|
Collabrations Overview | Research | Educational Activities | Services | Facilities | Faculty | Employment | News | CGT Home
|
|
|
To Offer Autologous Stem/Progenitor Cells (MSCs) for Clinical Trials The Center for Gene Therapy at Tulane University Health Sciences Center is preparing to offer stem/progenitor cells (MSCs) for use in Phase I/II clinical trials. The Center is accepting bone marrow aspirates from patients and is able to produce 100 million or more MSCs within two to three weeks. The Center seeks collaborations with clinical investigators in the continental U.S. who wish to generate INDs for therapies with MSCs. For more information, please contact: Darwin J. Prockop, M.D., Ph.D., Center for Gene Therapy, Tulane University Health Sciences Center, 1430 Tulane Avenue, SL-99, New Orleans, LA 70112; E-mail: dprocko@tulane.edu; Phone: 504-988-7711. |
|